An update on the condition of Josh Hardy, a young Virginia boy who battled a drug company for access to a life-saving drug.
After intense public scrutiny, Chimerix will provide medication for Josh Hardy, 7, who has been suffering from a bone marrow disorder as a result of cancer treatments.
On Monday’s Fox and Friends, we shared with you the story about a seven-year-old Virginia boy who is being denied a drug needed to treat a curable virus. This morning, Peter Johnson Jr. had a heartbreaking update to the story.
Peter Johnson Jr. reported this morning on a harrowing story pitting the family of a seven-year-old Virginia boy against a drug company. Josh Hardy was stricken with an infection called an adenovirus after undergoing a bone marrow transplant in January.